JPRN-UMIN000052822已完成Unknown
A placebo-controlled, double-blind, randomized, comparative trial concerning body composition effected by continuously taking test food in healthy adults with mildly obese. - A placebo-controlled, double-blind, randomized, comparative trial concerning body composition effected by continuously taking test food in healthy adults with mildly obese.
utrione Co., Ltd0 个研究点目标入组 80 人开始时间: 2023年12月6日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Have serious illnesses, or a history of malignant tumor in 6 months or serious illnesses. 2. Have took medicines, quasi-drug, foods or supplements affecting body weight and body fat, or treatment of obesity in one month. 3. Have had bariatric surgery in the past year or are planning to undergo surgery within 6 months after obtaining informed consent. 4. Are obese or overweight due to endocrine diseases, or under treatment or medication for gastrointestinal diseases, or have those history. 5. Have a psychologically serious medical history or illness, or a history of alcohol or other drug abuse. 6. Are judged to be unable to exercise due to skeletal muscle disease. 7. Have lost 3 kg or more of their body weight within the past 3 months. 8. Currently receiving any medical treatment with drugs or Chinese herbs. Medications used as needed are acceptable. 9. Receive diet or exercise therapy under medical supervision. 10. Have been taking quasi-drugs, foods, or supplements that affect the outcome of the study. Who can discontinue intake during the study is acceptable. 11. Have allergies to drugs or foods. 12. Shift workers. 13. Plans to extremely change lifestyle during the study. 14. Alcohol drinkers, over an average of 40 g/day. 15. Plans to travel abroad during the study period. 16. Are currently pregnant or breastfeeding, or planning to become pregnant during the study. 17. Have above 200 mL blood donation within one month, or above 400 mL blood donation within 3 months before this study. 18. Had joined other clinical trials from one month before the trial, have currently been joined other clinical trials, or plans to join other clinical trials during the study. 19. Are obsessed with orthopedic metal devices. 20. Are unsuitable for the study, judged by the principal investigator.
研究者
相似试验
已完成
Unknown
A placebo-controlled, double-blind, randomized, comparative superiority trial concerning subjective physical symptoms effected by taking lactic acid bacteria in healthy adults.Healthy adultsJPRN-UMIN000051260IMEQRD Co., Ltd200
已完成
不适用
A double-blind, randomized, placebo-controlled, combined single and multiple ascending dose study to investigate the safety, tolerability and pharmacokinetic profile of AB928 in healthy volunteers.NL-OMON46373Arcus Biosciences, Inc.86
招募中
不适用
STUDY to understand the effect and tolerance of Experimental product in patient with UPPER RESPIRATORY TRACT INFECTIONS (URTI)CTRI/2021/09/036807Vedic Lifesciences Pvt Ltd
进行中（未招募）
1 期
A double-blind, placebo controlled, randomized, comparative, mono-centre trial to assess the effects on the androgen metabolism and its effects on biochemical parameters, mood, fat, muscle and bone of continuous supplementation with dehydroepiandrosterone in women using a monophasic contraception containing drospirenone and ethinylestradiol - AMUSABiochemical disturbances (androgens, lipids, bone markers, endocrine) and mood disturbances caused by the use of Oral Contraception (OC).EUCTR2007-003788-28-BEPantarhei Bioscience B.V.99
进行中（未招募）
1 期
A double-blind, placebo controlled, randomized, comparative, mono-centre trial to assess the impact of a monthly administration of 50.000 IU of Vitamin D during 6 months on Vitamin D level in healthy young adult volunteers. - D-plusEUCTR2010-022454-17-BEniversity of Liège- Dpt de Médecine Générale